ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

TEAD4-driven GPX8 promotes temozolomide resistance in glioma by facilitating CTHRC1 expression to suppress mitochondrial oxidative stress.

Xiao Yu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.